Cargando…

Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma

BACKGROUND: Emerging evidence indicates that immunogenicity plays an important role in intrahepatic cholangiocarcinoma (ICC). Herein, we systematically evaluated the clinical relevance of immunogenicity in ICC. METHODS: Highly immunogenic ICCs identified in the public dataset and the Cancer Immunome...

Descripción completa

Detalles Bibliográficos
Autores principales: Konishi, Daisuke, Umeda, Yuzo, Yoshida, Kazuhiro, Shigeyasu, Kunitoshi, Yano, Shuya, Toji, Tomohiro, Takeda, Sho, Yoshida, Ryuichi, Yasui, Kazuya, Fuji, Tomokazu, Matsumoto, Kazuyuki, Kishimoto, Hiroyuki, Michiue, Hiroyuki, Teraishi, Fuminori, Kato, Hironari, Tazawa, Hiroshi, Yanai, Hiroyuki, Yagi, Takahito, Goel, Ajay, Fujiwara, Toshiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381563/
https://www.ncbi.nlm.nih.gov/pubmed/35597869
http://dx.doi.org/10.1038/s41416-022-01838-y
_version_ 1784769107179077632
author Konishi, Daisuke
Umeda, Yuzo
Yoshida, Kazuhiro
Shigeyasu, Kunitoshi
Yano, Shuya
Toji, Tomohiro
Takeda, Sho
Yoshida, Ryuichi
Yasui, Kazuya
Fuji, Tomokazu
Matsumoto, Kazuyuki
Kishimoto, Hiroyuki
Michiue, Hiroyuki
Teraishi, Fuminori
Kato, Hironari
Tazawa, Hiroshi
Yanai, Hiroyuki
Yagi, Takahito
Goel, Ajay
Fujiwara, Toshiyoshi
author_facet Konishi, Daisuke
Umeda, Yuzo
Yoshida, Kazuhiro
Shigeyasu, Kunitoshi
Yano, Shuya
Toji, Tomohiro
Takeda, Sho
Yoshida, Ryuichi
Yasui, Kazuya
Fuji, Tomokazu
Matsumoto, Kazuyuki
Kishimoto, Hiroyuki
Michiue, Hiroyuki
Teraishi, Fuminori
Kato, Hironari
Tazawa, Hiroshi
Yanai, Hiroyuki
Yagi, Takahito
Goel, Ajay
Fujiwara, Toshiyoshi
author_sort Konishi, Daisuke
collection PubMed
description BACKGROUND: Emerging evidence indicates that immunogenicity plays an important role in intrahepatic cholangiocarcinoma (ICC). Herein, we systematically evaluated the clinical relevance of immunogenicity in ICC. METHODS: Highly immunogenic ICCs identified in the public dataset and the Cancer Immunome Atlas (TCIA) were assessed to determine the prognostic impact of immunogenicity in ICC and key components after curative resection. We also investigated the clinical relevance of the immune milieu in ICC. RESULTS: Using the Gene Expression Omnibus dataset 89749 and TCIA, we identified CD8(+)/forkhead box P3 (FoxP3)(+) tumour-infiltrating lymphocytes (TILs), T-cell immunoglobulin and mucin domain 3 (TIM-3) and human leukocyte antigen-A (HLA-A) in highly immunogenic ICCs. Immunohistochemical analysis of the in-house cohort showed that intratumoral FoxP3(+) TILs correlated with CD8(+) TILs (P = 0.045, Fisher’s exact test) and that high FoxP3(+)/CD8(+) ratio (FCR) was an important marker for poor survival (P < 0.001, log-rank test). Furthermore, the FCR was higher in tumour-free lymph nodes in ICCs with lymph node metastases than in those without lymph node metastases (P = 0.003, Mann–Whitney U test). CONCLUSIONS: FCR should be considered an important biomarker that represents the immune environment of ICC based on its potentially important role in tumour progression, especially lymph node metastasis.
format Online
Article
Text
id pubmed-9381563
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-93815632022-08-18 Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma Konishi, Daisuke Umeda, Yuzo Yoshida, Kazuhiro Shigeyasu, Kunitoshi Yano, Shuya Toji, Tomohiro Takeda, Sho Yoshida, Ryuichi Yasui, Kazuya Fuji, Tomokazu Matsumoto, Kazuyuki Kishimoto, Hiroyuki Michiue, Hiroyuki Teraishi, Fuminori Kato, Hironari Tazawa, Hiroshi Yanai, Hiroyuki Yagi, Takahito Goel, Ajay Fujiwara, Toshiyoshi Br J Cancer Article BACKGROUND: Emerging evidence indicates that immunogenicity plays an important role in intrahepatic cholangiocarcinoma (ICC). Herein, we systematically evaluated the clinical relevance of immunogenicity in ICC. METHODS: Highly immunogenic ICCs identified in the public dataset and the Cancer Immunome Atlas (TCIA) were assessed to determine the prognostic impact of immunogenicity in ICC and key components after curative resection. We also investigated the clinical relevance of the immune milieu in ICC. RESULTS: Using the Gene Expression Omnibus dataset 89749 and TCIA, we identified CD8(+)/forkhead box P3 (FoxP3)(+) tumour-infiltrating lymphocytes (TILs), T-cell immunoglobulin and mucin domain 3 (TIM-3) and human leukocyte antigen-A (HLA-A) in highly immunogenic ICCs. Immunohistochemical analysis of the in-house cohort showed that intratumoral FoxP3(+) TILs correlated with CD8(+) TILs (P = 0.045, Fisher’s exact test) and that high FoxP3(+)/CD8(+) ratio (FCR) was an important marker for poor survival (P < 0.001, log-rank test). Furthermore, the FCR was higher in tumour-free lymph nodes in ICCs with lymph node metastases than in those without lymph node metastases (P = 0.003, Mann–Whitney U test). CONCLUSIONS: FCR should be considered an important biomarker that represents the immune environment of ICC based on its potentially important role in tumour progression, especially lymph node metastasis. Nature Publishing Group UK 2022-05-21 2022-09-01 /pmc/articles/PMC9381563/ /pubmed/35597869 http://dx.doi.org/10.1038/s41416-022-01838-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Konishi, Daisuke
Umeda, Yuzo
Yoshida, Kazuhiro
Shigeyasu, Kunitoshi
Yano, Shuya
Toji, Tomohiro
Takeda, Sho
Yoshida, Ryuichi
Yasui, Kazuya
Fuji, Tomokazu
Matsumoto, Kazuyuki
Kishimoto, Hiroyuki
Michiue, Hiroyuki
Teraishi, Fuminori
Kato, Hironari
Tazawa, Hiroshi
Yanai, Hiroyuki
Yagi, Takahito
Goel, Ajay
Fujiwara, Toshiyoshi
Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma
title Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma
title_full Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma
title_fullStr Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma
title_full_unstemmed Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma
title_short Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma
title_sort regulatory t cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381563/
https://www.ncbi.nlm.nih.gov/pubmed/35597869
http://dx.doi.org/10.1038/s41416-022-01838-y
work_keys_str_mv AT konishidaisuke regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT umedayuzo regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT yoshidakazuhiro regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT shigeyasukunitoshi regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT yanoshuya regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT tojitomohiro regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT takedasho regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT yoshidaryuichi regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT yasuikazuya regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT fujitomokazu regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT matsumotokazuyuki regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT kishimotohiroyuki regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT michiuehiroyuki regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT teraishifuminori regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT katohironari regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT tazawahiroshi regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT yanaihiroyuki regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT yagitakahito regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT goelajay regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma
AT fujiwaratoshiyoshi regulatorytcellsinduceasuppressiveimmunemilieuandpromotelymphnodemetastasisinintrahepaticcholangiocarcinoma